Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Patent
1995-09-21
1999-11-02
Caputa, Anthony C.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
A61K 3808
Patent
active
059773006
ABSTRACT:
Tumor rejection antigens presented by HLA-B44 molecules are described. These peptides are useful in diagnostic and therapeutic methodologies. The tumor rejection antigens are not derived from tyrosinase, which has previously been identified as a tumor rejection antigen precursor processed to an antigen presented by HLA-B44.
REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
patent: 5405940 (1995-04-01), Boon et al.
Nisco et al. Journal of Immunology 92:5845-5849, Apr. 1994.
Kunimatsu et al. Biochemical and Biophysical Research 164(2):875-882, Oct. 1989.
Parker et al. Journal of Immunology 149:3580-87, Dec. 1992.
Englehard, V.H. Current Opinion in Immunol. 6:13-23, 1994.
Burgess et al. The Journal of Cell Biology 111:2129-38, Nov. 1990.
Lazar et al Molecular and Cellular Biology 8(3):1247-52, Mar. 1988.
Kumar et al. PNAS 87:1337-1341, Feb. 1990.
Salgaller et al. Cancer Immunol. Immunother. 39(2):105-116, Aug. 1994.
Van der Bruggen et al., "A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes On a Human Melanoma", Science 254: 1643-1647 (Dec. 1991).
Khanna et al., "Localization of Epstein-Barr Virus Cytotoxic T Cell Epitopes Using Recombinant Vaccinia: Implications for Vaccine Development", J. Exp. Med. 176: 169-176 (Jul. 1992).
Kita et al., "HLA-B44-restricted Cytotoxic T Lymphocytes Recognizing An Epitope on Hepatitis C Virus Nucleocapsid Protein", Hepatology 18(5): 1039-1044 (1993).
Thorpe, et al., "Prediction of an HLA-B44 Binding Motif By The Alignment of Known Epitopes And Molecular Modeling of The Antigen Binding Cleft", Immunogenetics 40: 303-305 (1994).
Fleischauer, et al., "Characterization of Natural Peptide Ligands for HLA-B4402 and -B4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain", Tissue Antigens 44: 311-317 (1994).
Ramensee et al., "MHC Ligands And Peptides Motifs: First Listing", Immunogenetics 41: 178-228 (1995).
Boon-Falleur Thierry
Coulie Pierre
Herman Jean
van der Bruggen Pierre
Caputa Anthony C.
Ludwig Institute of Cancer Research
LandOfFree
Isolated nonapeptide which bind to HLA-B44 molecules and the use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nonapeptide which bind to HLA-B44 molecules and the use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nonapeptide which bind to HLA-B44 molecules and the use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2136861